Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
FDC LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:531599NSE Symbol: FDCP/E(TTM):24.55
ISIN Demat:INE258B01022Div & Yield %:0EPS(TTM):18.19
Book Value(Rs):121.05335Market Cap ( Cr.):7271.1Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
INCOME :      
Sales Turnover 1777.031518.971325.451331.091075.871070.21
Excise Duty0.000.000.000.000.008.02
Net Sales1777.031518.971325.451331.091075.871062.19
Other Income 53.9178.7397.1582.6654.8051.25
Stock Adjustments 11.8765.2625.50-4.6121.932.80
Total Income1842.811662.961448.101409.141152.601116.24
EXPENDITURE :      
Raw Materials 666.13593.10437.55419.92366.42352.78
Power & Fuel Cost34.0828.8927.0627.3824.6021.98
Employee Cost 386.99339.97294.31276.18226.19215.47
Other Manufacturing Expenses 137.67112.3584.8283.2181.0075.08
Selling and Administration Expenses 285.28232.70155.89159.55137.50136.49
Miscellaneous Expenses 24.1830.3626.9976.6646.0344.10
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure1534.321337.381026.621042.90881.74845.90
Operating Profit308.49325.58421.47366.23270.87270.35
Interest 4.043.053.403.411.431.40
Gross Profit304.45322.53418.07362.82269.44268.95
Depreciation38.7637.0837.6237.3633.1435.04
Profit Before Tax265.69285.45380.45325.46236.30233.91
Tax69.0068.0084.5282.8066.6067.80
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-4.28-2.181.44-4.12-1.84-2.21
Reported Net Profit200.97219.64294.49246.78171.54168.31
Extraordinary Items 4.325.2219.394.39-0.21-4.06
Adjusted Net Profit196.65214.42275.10242.39171.75172.37
Adjst. below Net Profit -31.341.13-21.99-3.43-0.39-1.67
P & L Balance brought forward1818.481597.721325.221095.57924.42805.94
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 500.000.000.0013.700.0048.16
P & L Balance carried down1488.111818.481597.721325.221095.57924.42
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.000.000.0080.000.000.00
Earnings Per Share-Unit Curr12.1113.0117.4514.439.799.61
Earnings Per Share(Adj)-Unit Curr12.1113.0117.4514.439.799.61
Book Value-Unit Curr119.39115.44102.0290.1881.8072.06